🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/12/2012 | 41,89 | 41,95 | 41,42 | 41,55 | -0,93% | 1,25% | 13.818.928 |
| 13/12/2012 | 42,88 | 42,88 | 41,89 | 41,94 | -2,89% | 2,31% | 14.404.131 |
| 12/12/2012 | 43,14 | 43,41 | 42,96 | 43,19 | +0,15% | 1,04% | 11.790.000 |
| 11/12/2012 | 42,61 | 43,21 | 42,46 | 43,12 | +1,60% | 1,75% | 14.235.508 |
| 10/12/2012 | 42,42 | 42,78 | 42,39 | 42,44 | -0,34% | 0,92% | 9.796.180 |
| 07/12/2012 | 42,49 | 42,60 | 42,14 | 42,59 | +0,27% | 1,08% | 8.247.236 |
| 06/12/2012 | 42,41 | 42,55 | 42,35 | 42,47 | +0,27% | 0,47% | 9.240.216 |
| 05/12/2012 | 42,30 | 42,71 | 42,20 | 42,36 | -0,02% | 1,20% | 12.206.056 |
| 04/12/2012 | 42,35 | 42,73 | 42,35 | 42,37 | -0,09% | 0,90% | 10.476.751 |
| 03/12/2012 | 42,43 | 42,78 | 42,39 | 42,40 | +0,32% | 0,92% | 12.177.865 |
| 30/11/2012 | 42,50 | 42,66 | 42,10 | 42,27 | -0,92% | 1,32% | 15.738.026 |
| 29/11/2012 | 42,89 | 42,89 | 42,44 | 42,66 | +0,25% | 1,05% | 10.018.356 |
| 28/11/2012 | 41,75 | 42,57 | 41,55 | 42,56 | +1,64% | 2,45% | 11.124.310 |
| 27/11/2012 | 42,01 | 42,17 | 41,84 | 41,87 | -0,72% | 0,77% | 9.294.922 |
| 26/11/2012 | 41,98 | 42,30 | 41,91 | 42,18 | -0,18% | 0,93% | 9.831.393 |
| 23/11/2012 | 41,98 | 42,26 | 41,91 | 42,25 | +0,89% | 0,84% | 4.692.734 |
| 21/11/2012 | 41,79 | 41,92 | 41,63 | 41,88 | +0,76% | 0,68% | 7.637.824 |
| 20/11/2012 | 41,43 | 41,67 | 41,26 | 41,56 | +0,51% | 0,99% | 11.428.545 |
| 19/11/2012 | 41,34 | 41,41 | 41,12 | 41,36 | +0,63% | 0,72% | 9.630.806 |
| 16/11/2012 | 40,88 | 41,25 | 40,42 | 41,10 | +0,63% | 2,03% | 17.435.052 |
| 15/11/2012 | 40,99 | 41,16 | 40,60 | 40,84 | -0,58% | 1,37% | 12.872.794 |
| 14/11/2012 | 41,70 | 41,89 | 40,94 | 41,08 | -1,44% | 2,27% | 14.888.831 |
| 13/11/2012 | 41,77 | 42,42 | 41,67 | 41,68 | -0,77% | 1,81% | 10.059.857 |
| 12/11/2012 | 42,43 | 42,48 | 41,87 | 42,00 | -0,07% | 1,44% | 7.681.630 |
| 09/11/2012 | 41,69 | 42,29 | 41,62 | 42,03 | +0,48% | 1,60% | 14.666.970 |
| 08/11/2012 | 42,47 | 42,72 | 41,83 | 41,83 | -1,39% | 2,09% | 17.113.735 |
| 07/11/2012 | 43,46 | 43,58 | 42,16 | 42,42 | -3,18% | 3,27% | 25.223.159 |
| 06/11/2012 | 43,60 | 44,20 | 43,59 | 43,82 | +0,55% | 1,40% | 9.154.594 |
| 05/11/2012 | 43,72 | 43,89 | 43,23 | 43,58 | -0,72% | 1,51% | 9.412.298 |
| 02/11/2012 | 44,13 | 44,42 | 43,88 | 43,89 | +0,13% | 1,21% | 11.580.924 |